Grace Therapeutics, Inc. (GRCE) › RevenueGrace Therapeutics, Inc. (GRCE) — RevenueAnnual figures by fiscal year, from SEC filings.2021: $196.0K2022: $0$02021Revenue (USD)2022Fiscal YearRevenueChange YoY2022$0-100.0%2021$196.0K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share